BME Seminar: Dr. Evan Scott - Engineering Self-Assembled Nanobiomaterials for Therapeutic Immunomodulation
Armour College of Engineering's Biomedical Engineering Department will host a seminar featuring Evan Scott, Assistant Professor of Biomedical Engineering at Northwestern University on March 3, 2017. Lecture topic will be Engineering Self-Assembled Nanobiomaterials for Therapeutic Immunomodulation.
Abstract
Self-assembled nanobiomaterials that are engineered to achieve specific biodistributions and mechanisms of degradation hold great promise for controlled stimulation of the immune system. Through the use of such rationally designed nanomaterials, we aim to investigate the basic inflammatory and immunological processes contributing to diverse pathologies and develop targeted immunotherapies. We specifically approach this by synthesizing, assembling and testing in vitro and in vivo a range of nanostructures loaded with strategically selected combinations of immunostimulants to achieve controlled elicitation or suppression of the immune system. Here, I will present some of our ongoing work in the areas of nanobiomaterials development, cardiovascular disease, and neonatal immunization
Speaker Bio
Evan Scott, Ph.D. has been as an Assistant Professor of Biomedical Engineering at Northwestern University since the fall of 2013. Dr. Scott is a recipient of the 2015 NIH Director’s New Innovator Award, the 2015 National Science Foundation CAREER Award and the 2014 American Heart Association Scientist Development Grant. He respectively received a B.S. and Ph.D. in Biomedical Engineering from Brown University in 2002 and Washington University in St. Louis in 2009. His dissertation work was performed in the laboratory of Prof. Donald Elbert, where he developed methods based in proteomics and polymer chemistry to both analyze and control the interactions between cells and material surfaces. As a Whitaker International Scholar, he then spent four years in Switzerland performing postdoctoral research in the laboratories of Prof. Jeffrey Hubbell and Prof. Melody Swartz at the École Polytechnique Fédérale de Lausanne (EPFL), one of the Swiss Federal Institutes of Technology. There he focused on the development of new formulations and strategies for both HIV vaccination and cancer immunotherapy as part of inter-institutional projects funded by the Bill and Melinda Gates Foundation. He has co-authored 21 peer-reviewed journal articles, 36 conference proceedings, and 4 US patents.
Attendance
To ensure that your attendance at the event is properly recorded in your IIT Engineering Themes Portfolio, please take a photo of the speaker and a "selfie" at the event and email it to engineering@iit.edu including your A# and the name of the event in the email.
Earn Engineering Themes credit in Health for attending.